<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36906677</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2730-664X</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>11</Day></PubDate></JournalIssue><Title>Communications medicine</Title><ISOAbbreviation>Commun Med (Lond)</ISOAbbreviation></Journal><ArticleTitle>Persistent COVID-19 symptoms in community-living older adults from the Canadian Longitudinal Study on Aging (CLSA).</ArticleTitle><Pagination><StartPage>36</StartPage><MedlinePgn>36</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">36</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s43856-023-00266-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Symptom persistence in non-hospitalized COVID-19 patients, also known as Long COVID or Post-acute Sequelae of COVID-19, is not well characterized or understood, and few studies have included non-COVID-19 control groups.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used data from a cross-sectional COVID-19 questionnaire (September-December 2020) linked to baseline (2011-2015) and follow-up (2015-2018) data from a population-based cohort including 23,757 adults 50+ years to examine how age, sex, and pre-pandemic physical, psychological, social, and functional health were related to the severity and persistence of 23 COVID-19-related symptoms experienced between March 2020 and questionnaire completion.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The most common symptoms are fatigue, dry cough, muscle/joint pain, sore throat, headache, and runny nose; reported by over 25% of participant who had (n&#x2009;=&#x2009;121) or did not have (n&#x2009;=&#x2009;23,636) COVID-19 during the study period. The cumulative incidence of moderate/severe symptoms in people with COVID-19 is more than double that reported by people without COVID-19, with the absolute difference ranging from 16.8% (runny nose) to 37.8% (fatigue). Approximately 60% of male and 73% of female participants with COVID-19 report at least one symptom persisting &gt;1 month. Persistence &gt;1 month is higher in females (aIRR&#x2009;=&#x2009;1.68; 95% CI: 1.03, 2.73) and those with multimorbidity (aIRR&#x2009;=&#x2009;1.90; 95% CI: 1.02, 3.49); persistence &gt;3 months decreases by 15% with each unit increase in subjective social status after adjusting for age, sex and multimorbidity.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Many people living in the community who were not hospitalized for COVID-19 still experience symptoms 1- and 3-months post infection. These data suggest that additional supports, for example access to rehabilitative care, are needed to help some individuals fully recover.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Griffith</LastName><ForeName>Lauren E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Labarge Centre for Mobility in Aging, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McMaster Institute for Research on Aging, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beauchamp</LastName><ForeName>Marla</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Labarge Centre for Mobility in Aging, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McMaster Institute for Research on Aging, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMillan</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7090-9485</Identifier><AffiliationInfo><Affiliation>Division of Geriatric Medicine, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borhan</LastName><ForeName>Sayem</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oz</LastName><ForeName>Urun Erbas</ForeName><Initials>UE</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolfson</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute of the McGill University Health Centre, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirkland</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Community Health &amp; Epidemiology, Dalhousie University, Halifax, NS, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basta</LastName><ForeName>Nicole E</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raina</LastName><ForeName>Parminder</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8107-3193</Identifier><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada. praina@mcmaster.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Labarge Centre for Mobility in Aging, McMaster University, Hamilton, ON, Canada. praina@mcmaster.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McMaster Institute for Research on Aging, McMaster University, Hamilton, ON, Canada. praina@mcmaster.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Canadian Longitudinal Study on Aging (CLSA) Team</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NA</GrantID><Agency>Public Health Agency of Canada (Agence de la Sant&#xe9; Publique du Canada)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Med (Lond)</MedlineTA><NlmUniqueID>9918250414506676</NlmUniqueID><ISSNLinking>2730-664X</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>Some people who develop COVID-19 experience persistence of symptoms. Here, we aimed to understand the factors associated with the severity and persistence of these symptoms in adults 50 years and older living in the community who had COVID-19. Using information provided by 23,757 participants from across Canada we compared the symptoms between those who had COVID-19 and those who did not. The number and severity of symptoms in participants who had COVID-19 was beyond what would be expected due to other causes. Over two-thirds of participants who had COVID-19 reported symptoms persisting for more than one month, and over half of the participants more than three months. Symptom persistence was higher in females, those with multiple chronic conditions, and lower perceived social status. This suggests that a substantial proportion of people who were not hospitalized for COVID-19 may require further healthcare assistance.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></OtherAbstract><CoiStatement>The authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Anderson</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Balion</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Costa</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Asada</LastName><ForeName>Yukiko</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cossette</LastName><ForeName>Beno&#x20b;t</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levasseur</LastName><ForeName>Melanie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hofer</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paterson</LastName><ForeName>Theone</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hogan</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liu-Ambrose</LastName><ForeName>Teresa</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menec</LastName><ForeName>Verena</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>St John</LastName><ForeName>Philip</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mugford</LastName><ForeName>Gerald</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gao</LastName><ForeName>Zhiwei</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taler</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davidson</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wister</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cosco</LastName><ForeName>Theodore</ForeName><Initials>T</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>11</Day><Hour>23</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36906677</ArticleId><ArticleId IdType="pmc">PMC10006564</ArticleId><ArticleId IdType="doi">10.1038/s43856-023-00266-0</ArticleId><ArticleId IdType="pii">10.1038/s43856-023-00266-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sudre CH, et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray T. Unpacking &#x201c;long COVID&#x201d;. CMAJ. 2021;193:E318&#x2013;E319. doi: 10.1503/cmaj.1095923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.1095923</ArticleId><ArticleId IdType="pmc">PMC8034303</ArticleId><ArticleId IdType="pubmed">33649174</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, et al. Long-term consequences of COVID-19: research needs. Lancet Infect. Dis. 2020;20:1115&#x2013;1117. doi: 10.1016/S1473-3099(20)30701-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30701-5</ArticleId><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Connection series no. 1. COVID-19 and the decade of healthy ageing. https://www.who.int/docs/default-source/decade-of-healthy-ageing/decade-connection-series&#x2013;covid-19-en.pdf?sfvrsn=d3f887b0_7 (2020).</Citation></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw. Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, et al. Characterising long COVID: a living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) Science. 2020;368:489&#x2013;493. doi: 10.1126/science.abb3221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb3221</ArticleId><ArticleId IdType="pmc">PMC7164387</ArticleId><ArticleId IdType="pubmed">32179701</ArticleId></ArticleIdList></Reference><Reference><Citation>Stringhini S, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396:313&#x2013;319. doi: 10.1016/S0140-6736(20)31304-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31304-0</ArticleId><ArticleId IdType="pmc">PMC7289564</ArticleId><ArticleId IdType="pubmed">32534626</ArticleId></ArticleIdList></Reference><Reference><Citation>Goertz, Y. M. J. et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res.6, 00542-2020 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson KB, et al. Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin. Infect. Dis. 2021;73:3826&#x2013;e829. doi: 10.1093/cid/ciab103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab103</ArticleId><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaber TAK, Ashish A, Unsworth A. Persistent post-covid symptoms in healthcare workers. Occup. Med. 2021;71:144&#x2013;146. doi: 10.1093/occmed/kqab043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqab043</ArticleId><ArticleId IdType="pmc">PMC8083525</ArticleId><ArticleId IdType="pubmed">33830208</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021;76:405&#x2013;407. doi: 10.1136/thoraxjnl-2020-216377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. 2021;325:2015&#x2013;2016. doi: 10.1001/jama.2021.5612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain MA, et al. Prevalence of long COVID symptoms in Bangladesh: a prospective inception cohort study of COVID-19 survivors. BMJ Glob. Health. 2021;6:e006838. doi: 10.1136/bmjgh-2021-006838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-006838</ArticleId><ArticleId IdType="pmc">PMC8671853</ArticleId><ArticleId IdType="pubmed">34906986</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Romieu AC, et al. Health care utilization and clinical characteristics of nonhospitalized adults in an integrated health care system 28-180 days after COVID-19 diagnosis - Georgia, May 2020-March 2021. MMWR Morb. Mortal. Wkly Rep. 2021;70:644&#x2013;650. doi: 10.15585/mmwr.mm7017e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7017e3</ArticleId><ArticleId IdType="pmc">PMC8084119</ArticleId><ArticleId IdType="pubmed">33914727</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, et al. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect. Dis. 2021;21:1373&#x2013;1382. doi: 10.1016/S1473-3099(21)00211-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J, et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern. Med. 2022;182:19&#x2013;25. doi: 10.1001/jamainternmed.2021.6454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Raina P, et al. Cohort Profile: The Canadian Longitudinal Study on Aging (CLSA) Int. J. Epidemiol. 2019;48:1752&#x2013;1753j. doi: 10.1093/ije/dyz173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyz173</ArticleId><ArticleId IdType="pmc">PMC6929533</ArticleId><ArticleId IdType="pubmed">31633757</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler NE, Epel ES, Castellazzo G, Ickovics JR. Relationship of subjective and objective social status with psychological and physiological functioning: preliminary data in healthy white women. Health Psychol. 2000;19:586&#x2013;592. doi: 10.1037/0278-6133.19.6.586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0278-6133.19.6.586</ArticleId><ArticleId IdType="pubmed">11129362</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh-Manoux A, Adler NE, Marmot MG. Subjective social status: its determinants and its association with measures of ill-health in the Whitehall II study. Soc. Sci. Med. 2003;56:1321&#x2013;1333. doi: 10.1016/S0277-9536(02)00131-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0277-9536(02)00131-4</ArticleId><ArticleId IdType="pubmed">12600368</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillenbaum GG, Smyer MA. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J. Gerontol. 1981;36:428&#x2013;434. doi: 10.1093/geronj/36.4.428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronj/36.4.428</ArticleId><ArticleId IdType="pubmed">7252074</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2021).</Citation></Reference><Reference><Citation>Evans RA, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir. Med. 2021;9:1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat. Commun. 2022;13:1957. doi: 10.1038/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Living guidance for clinical management of COVID-19: living guidance. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2 (2021).</Citation></Reference><Reference><Citation>Beauchamp MK, et al. Canadian Thoracic Society position statement on rehabilitation for COVID-19 and implications for pulmonary rehabilitation. Can. J. Respir. Crit. Care Sleep Med. 2022;6:9&#x2013;13.</Citation></Reference><Reference><Citation>Garg S, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, March 1-30, 2020. MMWR Morb. Mortal. Wkly Rep. 2020;69:458&#x2013;464. doi: 10.15585/mmwr.mm6915e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6915e3</ArticleId><ArticleId IdType="pmc">PMC7755063</ArticleId><ArticleId IdType="pubmed">32298251</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun. 2022;13:3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoebel J, Lampert T. Subjective social status and health: multidisciplinary explanations and methodological challenges. J. Health Psychol. 2020;25:173&#x2013;185. doi: 10.1177/1359105318800804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1359105318800804</ArticleId><ArticleId IdType="pubmed">30230391</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J. Med. Virol. 2021;93:1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb Hooper M, et al. Associations between perceived racial discrimination and tobacco cessation among diverse treatment seekers. Ethn. Dis. 2020;30:411&#x2013;420. doi: 10.18865/ed.30.3.411.</Citation><ArticleIdList><ArticleId IdType="doi">10.18865/ed.30.3.411</ArticleId><ArticleId IdType="pmc">PMC7360180</ArticleId><ArticleId IdType="pubmed">32742143</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Agency of Canada. COVID-19 epidemiology update. https://health-infobase.canada.ca/covid-19/ (2022).</Citation></Reference><Reference><Citation>Iyer AS, et al. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci. Immunol. 2020;5:eabe0367. doi: 10.1126/sciimmunol.abe0367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abe0367</ArticleId><ArticleId IdType="pmc">PMC7857394</ArticleId><ArticleId IdType="pubmed">33033172</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Update 54 &#x2013; clinical long-term effects of COVID-19. https://www.who.int/publications/m/item/update-54-clinical-long-term-effects-of-covid-19 (2019).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>